MK0359

DRUG3 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

AsthmaPulmonary Disease, Chronic ObstructiveRheumatoid Arthritis

Phase 2

Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017)

CompletedNCT00482417

Merck Sharp & Dohme LLCRheumatoid Arthritis

Start: 2002-12-31End: 2003-05-31Updated: 2015-11-20

A Study of MK0359 in Patients With Chronic Asthma (0359-013)

CompletedNCT00482898

Merck Sharp & Dohme LLCAsthma

Start: 2002-09-30End: 2003-04-30Updated: 2015-05-27

A Study of MK0359 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0359-016)

CompletedNCT00482235

Merck Sharp & Dohme LLCPulmonary Disease, Chronic Obstructive

Start: 2002-12-31End: 2003-04-30Updated: 2015-12-02

Related Papers

Randomized, placebo-controlled study of a selective PDE4 inhibitor in the treatment of asthma.

2009-01-0813 citations